Fenofibrate and Movement - uncoordinated - a phase IV clinical study of FDA data

Summary:

Movement - uncoordinated is reported as a side effect among people who take Fenofibrate (fenofibrate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pantoprazole, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Movement - uncoordinated when taking Fenofibrate. It is created by eHealthMe based on reports of 39,402 people who have side effects when taking Fenofibrate from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Movement - uncoordinated?

Movement - uncoordinated is found to be associated with 1,104 drugs and 2,270 conditions by eHealthMe. Check the latest studies of Movement - uncoordinated.

On May, 31, 2026

39,402 people reported to have side effects when taking Fenofibrate.
Among them, 34 people (0.09%) have Movement - uncoordinated.

Could Fenofibrate cause Movement - uncoordinated?

Among these 34 people:

How long have people been on Fenofibrate when they have Movement - uncoordinated? *

What is the gender of people who have Movement - uncoordinated when taking Fenofibrate? *

female: 57.58 %
male: 42.42 %

What is the age of people who have Movement - uncoordinated when taking Fenofibrate? *

What are other drugs people take besides Fenofibrate? *

What are other side effects people have besides Movement - uncoordinated? *

Headache (pain in head): 13 people, 38.24%
Confusional State: 12 people, 35.29%
Tremor (trembling or shaking movements in one or more parts of your body): 11 people, 32.35%
Diarrhea: 11 people, 32.35%
Delusion (a false belief or opinion): 10 people, 29.41%
Fall: 8 people, 23.53%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 23.53%
Leukopenia (less number of white blood cells in blood): 7 people, 20.59%
Aggression: 7 people, 20.59%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 20.59%

What are the existing conditions these people have? *

Agitation (state of anxiety or nervous excitement): 7 people, 20.59%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 7 people, 20.59%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 7 people, 20.59%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 20.59%
Affective Disorder (mental disorder): 6 people, 17.65%
Pain: 6 people, 17.65%
Bipolar Disorder (mood disorder): 4 people, 11.76%
Constipation: 2 people, 5.88%
Post-Traumatic Stress Disorder: 2 people, 5.88%
Neuropathy Peripheral (surface nerve damage): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and have Movement - uncoordinated?

- Check whether Movement - uncoordinated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fenofibrate:

Fenofibrate (40,457 reports)

Browse all side effects of Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Movement - uncoordinated:

Movement - uncoordinated (1,104 drugs)

Browse all the conditions that are associated with Movement - uncoordinated:

Movement - uncoordinated (2,270 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Fenofibrate) and Fenofibrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.